Dashboard
Discussions
Watchlists
Collections
Tools
More
Events
SIGN UP
SIGN IN
ENTITY
Eubiologics (206650 KS)
Watchlist
28
Analysis
Health Care
•
South Korea
Eubiologics Co. Ltd. researches and develops biopharmaceuticals. The Company offers bacterial vaccines for new epidemics and antibiotic resistance. Eubiologics operates in South Korea.
more
Watchlist
All
Insights
Broker
Sponsored
Syndicated
Podcast
Buy side
Refresh
Focused
Suggested
bullish
•
Smartkarma
•
14 Jan 2017 16:34
Smartkarma - ECM Coverage Weekly Update (16 Jan 2017)
Smartkarma ECM Team puts out a weekly update on the deals we have covered recently, along with updates for upcoming IPOs.Accuracy Rate:It's only...
Zhen Zhou, Toh
196 Views
Share
bullish
•
Eubiologics
•
13 Jan 2017 00:29
Eubiologics IPO Part 3 - IPO Bookbuilding Results & Personal View
Eubiologics IPO price was set at ₩6,000, the lowest end of the indicative price band, after conducting the demand survey (bookbuilding) (Jan 9-10)...
Sanghyun Park
Follow
462 Views
Share
bullish
•
Eubiologics
•
10 Jan 2017 16:02
Eubiologics IPO Part 2 - Growth Potential & Appropriate Valuation Level
* In Part 2 (as below), I examined the company's business fundamentals in more detail along with its growth potential and appropriate valuation...
Sanghyun Park
Follow
209 Views
Share
bullish
•
Eubiologics
•
08 Jan 2017 02:20
Eubiologics IPO Part 1 - Schedule, Financials & Valuation
Eubiologics is a very "young" vaccine company that develops an oral cholera vaccine product called "Euvichol". This company will be Korea's first...
Sanghyun Park
Follow
350 Views
Share
bullish
•
Thematic (Sector/Industry)
•
07 Jul 2016 00:13
SillaJen's December IPO: Valuation, Growth Expectation and IPO Timing
SillaJen Biotherapeutics (established in 2006) is indeed a rare breed in Korean pharmaceutical world. It is not a generic drug maker. It is not a...
Sanghyun Park
Follow
3.4k Views
Share
First
Previous
1
2
3
4
5
6
Next
Last
Copyright © 2022 Smartkarma Innovations Pte Ltd. All Rights Reserved. v3.33.7
x